Media coverage about Imperva (NYSE:IMPV) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Imperva earned a coverage optimism score of 0.21 on Accern’s scale. Accern also gave news coverage about the software maker an impact score of 45.2906542018544 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the news articles that may have impacted Accern’s analysis:
- Stock Traders Buy Large Volume of Imperva Call Options (IMPV) (americanbankingnews.com)
- Head to Head Analysis: Gartner (IT) & Imperva (IMPV) (americanbankingnews.com)
- Notable Tuesday Option Activity: NVDA, IMPV, CNX – Nasdaq (nasdaq.com)
- Iridium Communications Inc. (IRDM) is at $12.70 per share and Imperva, Inc. (IMPV) is listed at $41.75 – Stocks Gallery (stocksgallery.com)
Shares of Imperva (IMPV) opened at $42.60 on Friday.
Several research firms recently commented on IMPV. ValuEngine cut Imperva from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Stifel Nicolaus restated a “hold” rating and issued a $47.00 target price on shares of Imperva in a research report on Friday, July 14th. KeyCorp restated a “hold” rating on shares of Imperva in a research report on Tuesday, October 24th. BidaskClub upgraded Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, September 12th. Finally, Stephens reiterated an “overweight” rating and set a $61.00 price target (up from $53.00) on shares of Imperva in a research report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $53.50.
In other news, Director Anthony J. Bettencourt sold 99,598 shares of the firm’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now directly owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.20% of the company’s stock.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
What are top analysts saying about Imperva Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imperva Inc and related companies.